 Connection
Kennon Heard to Liver
This is a "connection" page, showing publications Kennon Heard has written about Liver.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.529 |
|
|
|
-
Green JL, Reifler LM, Heard KJ. Validity of a point of care device (Cholestech LDX) to monitor liver enzyme activity (aminotransferase measures) during a clinical trial. Contemp Clin Trials. 2010 Jul; 31(4):279-82.
Score: 0.206
-
Monte AA, Arriaga Mackenzie I, Pattee J, Kaiser S, Willems E, Rumack B, Reynolds KM, Dart RC, Heard KJ. Genetic variants associated with ALT elevation from therapeutic acetaminophen. Clin Toxicol (Phila). 2022 11; 60(11):1198-1204.
Score: 0.121
-
Yip L, Heard K. Potential adjunct treatment for high-risk acetaminophen overdose. Clin Toxicol (Phila). 2016 Jun; 54(5):459.
Score: 0.077
-
Dart RC, Green JL, Kuffner EK, Heard K, Sproule B, Brands B. The effects of paracetamol (acetaminophen) on hepatic tests in patients who chronically abuse alcohol - a randomized study. Aliment Pharmacol Ther. 2010 Aug; 32(3):478-86.
Score: 0.052
-
Heard KJ. Acetylcysteine for acetaminophen poisoning. N Engl J Med. 2008 Jul 17; 359(3):285-92.
Score: 0.045
-
Sonn BJ, Heard KJ, Heard SM, D'Alessandro A, Reynolds KM, Dart RC, Rumack BH, Monte AA. Metabolomic markers predictive of hepatic adaptation to therapeutic dosing of acetaminophen. Clin Toxicol (Phila). 2022 Feb; 60(2):221-230.
Score: 0.028
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|